Denali Therapeutics Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Denali Therapeutics Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Denali Therapeutics Inc. Operating Lease, Payments for the quarter ending June 30, 2024 was $2.85M, a 3.29% increase year-over-year.
  • Denali Therapeutics Inc. Operating Lease, Payments for the twelve months ending June 30, 2024 was $11.2M, a 3.61% decline year-over-year.
  • Denali Therapeutics Inc. annual Operating Lease, Payments for 2023 was $11.3M, a 1.39% increase from 2022.
  • Denali Therapeutics Inc. annual Operating Lease, Payments for 2022 was $11.2M, a 8.25% increase from 2021.
  • Denali Therapeutics Inc. annual Operating Lease, Payments for 2021 was $10.3M, a 6.15% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $11.3M +$156K +1.39% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $11.2M +$853K +8.25% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $10.3M +$599K +6.15% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $9.74M +$4.32M +79.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 $5.42M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.